PharmNovo AB

SE-223 81 (Unknown)

Start Date End Date Funded Value Relevance

CSV

25 50 100

£396,900

Aug 16 - Oct 19

MICA: Defining G protein- and arrestin-dependent signalling pathways of biased DOPr agonists and the relevance to their in vivo effects

MRC award to University of Bristol and Eamonn Kelly

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}